Filed: 2/13/2026ACC: 0001813845-26-000002
π What this filing means
BIOS CAPITAL MANAGEMENT, LP filed this quarterly 13FβHR report disclosing 6 equity positions with a total reported market value of $82.62M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
6
Positions
$82.62M
Total AUM (reported)
22.69M
Total Shares
Allocation by class
COM$80.07M96.9%
COM NEW$2.55M3.1%
Portfolio Concentration
Top 3$77.01M93.2%
4β10$5.61M6.8%
Top 3 weight
93.2%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 22.69M
Sole
Full voting authority
0.00
shares
% of voting shares0.0%
Shared
Joint voting authority
22.69M
shares
% of voting shares100.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other6
Dominant voting typeShared Β· 100.0% of voting shares
Institutional Holdings6
Rows:
ACTUATE THERAPEUTICS INC
DFNDShares10.05M
TypeSH
Market value$61.51M
74.44%
Sole
0.00
Shared
10.05M
None
0.00
COGNITION THERAPEUTICS INC
OTRShares6M
TypeSH
Market value$8.10M
9.80%
Sole
0.00
Shared
6M
None
0.00
OPUS GENETICS INC
OTRShares3.68M
TypeSH
Market value$7.40M
8.96%
Sole
0.00
Shared
3.68M
None
0.00
LANTERN PHARMA INC
OTRShares1.01M
TypeSH
Market value$3.06M
3.70%
Sole
0.00
Shared
1.01M
None
0.00
REIN THERAPEUTICS INC
OTRShares1.69M
TypeSH
Market value$1.96M
2.37%
Sole
0.00
Shared
1.69M
None
0.00
IN8BIO INC
OTRShares253.42K
TypeSH
Market value$593.0K
0.72%
Sole
0.00
Shared
253.42K
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting β Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ACTUATE THERAPEUTICS INCDFND | COM | 10.05M | SH | $61.51M 74.44% | 0.00 | 10.05M | 0.00 |
COGNITION THERAPEUTICS INCOTR | COM | 6M | SH | $8.10M 9.80% | 0.00 | 6M | 0.00 |
OPUS GENETICS INCOTR | COM | 3.68M | SH | $7.40M 8.96% | 0.00 | 3.68M | 0.00 |
LANTERN PHARMA INCOTR | COM | 1.01M | SH | $3.06M 3.70% | 0.00 | 1.01M | 0.00 |
REIN THERAPEUTICS INCOTR | COM NEW | 1.69M | SH | $1.96M 2.37% | 0.00 | 1.69M | 0.00 |
IN8BIO INCOTR | COM NEW | 253.42K | SH | $593.0K 0.72% | 0.00 | 253.42K | 0.00 |